Literature DB >> 9131778

Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.

M J Nirenberg1, J Chan, Y Liu, R H Edwards, V M Pickel.   

Abstract

The vesicular monoamine transporter-2 (VMAT2) mediates the reserpine-sensitive neuronal uptake of monoamines into vesicles and other intracellular organelles. Accordingly, this transporter is expressed at high levels in regions that contain a dense monoamine innervation, such as the rat dorsolateral striatum. We used ultrastructural immunocytochemistry in this region to show that immunogold labeling for VMAT2 is present in varicose axonal processes, many of which also contain the catecholamine-synthesizing enzyme tyrosine-hydroxylase. Within these mainly dopaminergic processes, VMAT2 was associated with small synaptic vesicles (SSVs) and more rarely with large dense-core vesicles or tubulovesicles. These findings suggest that SSVs are the major organelles involved in the storage and release of dopamine in the dorsolateral striatum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131778     DOI: 10.1002/(SICI)1098-2396(199706)26:2<194::AID-SYN10>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  27 in total

1.  Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.

Authors:  E N Pothos; K E Larsen; D E Krantz; Y Liu; J W Haycock; W Setlik; M D Gershon; R H Edwards; D Sulzer
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

Review 2.  Extrasynaptic release of GABA and dopamine by retinal dopaminergic neurons.

Authors:  Hajime Hirasawa; Massimo Contini; Elio Raviola
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

3.  Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Authors:  Torun Malmlöf; Kristin Feltmann; Åsa Konradsson-Geuken; Frank Schneider; Rudolf-Giesbert Alken; Torgny H Svensson; Björn Schilström
Journal:  J Neural Transm (Vienna)       Date:  2014-06-07       Impact factor: 3.575

4.  Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size.

Authors:  E N Pothos; V Davila; D Sulzer
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

Review 5.  Heterogeneity of dopamine release sites in health and degeneration.

Authors:  Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2019-11-05       Impact factor: 5.996

Review 6.  H2O2: a dynamic neuromodulator.

Authors:  Margaret E Rice
Journal:  Neuroscientist       Date:  2011-06-10       Impact factor: 7.519

7.  Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.

Authors:  Dominik K Biezonski; Brian J Piper; Nina M Shinday; Peter J Kim; Syed F Ali; Jerrold S Meyer
Journal:  Eur J Pharmacol       Date:  2012-12-28       Impact factor: 4.432

8.  A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles.

Authors:  Etienne A Cartier; Leonardo A Parra; Tracy B Baust; Marisol Quiroz; Gloria Salazar; Victor Faundez; Loreto Egaña; Gonzalo E Torres
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

9.  Functional heterogeneity at dopamine release sites.

Authors:  James A Daniel; Sally Galbraith; Lorraine Iacovitti; Andrea Abdipranoto; Bryce Vissel
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

10.  Pancreatic innervation in mouse development and beta-cell regeneration.

Authors:  R E Burris; M Hebrok
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.